CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

J&J hits all-time high as UBS assumes Buy on transition to growth

Positive
AI Analysis

Summary

Johnson & Johnson reached an all-time high stock price following UBS initiating a Buy rating on the company's transition to growth.

Importance:3/10
Sentiment:
0.60
analyst_ratingstock_performancebusiness_strategy
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on September 2, 2026 4:08 PM

Read Original